๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

23 recruiting trials

for Primary IgA Nephropathy

A Study of SHR-2173 in Participants With Primary IgA Nephropathy NCT07354932Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Shanghai Guangdong Hengrui Pharmaceutical Co., Ltd ยท Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection, Placebo The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA) NCT04858724n/a1 site๐Ÿ“ Shanghai Ruijin Hospital A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy NCT04557462Phase 3161 sites๐Ÿ“ Glendale๐Ÿ“ San Diego๐Ÿ“ San Dimas Novartis Pharmaceuticals ยท Tests: LNP023 A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy NCT07616700Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Haisco Pharmaceutical Group Co., Ltd. ยท Tests: HSK39297 200mgQD, HSK39297 300mgQD RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN) NCT06926244n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy NCT07606352Phase 28 sites๐Ÿ“ Newcastle๐Ÿ“ Penrith๐Ÿ“ Sydney Sitala Bio LTD ยท Tests: STL303, STL303, Placebo capsule A Trial of HRS-5965 Capsule in Primary IgA Nephropathy NCT07014826Phase 31 site๐Ÿ“ Beijing Chengdu Suncadia Medicine Co., Ltd. ยท Tests: HRS-5965, Placebo Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN NCT06994845Phase 320 sites๐Ÿ“ Madera๐Ÿ“ Aurora๐Ÿ“ Gainesville Novartis Pharmaceuticals ยท Tests: iptacopan Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (โ‰ฅ18 Years) Primary IgA Nephropathy? NCT06676384Phase 412 sites๐Ÿ“ Nadiฤd๐Ÿ“ Mysuru๐Ÿ“ Udupi Christian Medical College, Vellore, India ยท Tests: Oral prednisolone and SoC, Gut-directed budesonide and SoC, Mycophenolate mofetil (MMF) and SoC, Hydroxychloroquine andโ€ฆ A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy NCT07582133Phase 21 site๐Ÿ“ Beijing Chengdu Suncadia Medicine Co., Ltd. ยท Tests: HRS-5965 Capsules A Study of YKST02 in Participants With Primary IgA Nephropathy NCT07498673EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: YKST02 Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN NCT07498335Phase 318 sites๐Ÿ“ Neptune City๐Ÿ“ Cincinnati๐Ÿ“ Oklahoma City Novartis Pharmaceuticals ยท Tests: Drug: Atrasentan Study of WAL0921 in Patients With Glomerular Kidney Diseases NCT06466135Phase 250 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Tamarac Walden Biosciences ยท Tests: WAL0921, Placebo PS-002 for the Treatment of IgA Nephropathy in Adults NCT07182227Phase 1, Phase 210 sites๐Ÿ“ Miami๐Ÿ“ Baltimore๐Ÿ“ Manchester Purespring Therapeutics Limited ยท Tests: PS-002 Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy. NCT07585981n/a1 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: NEFECON Phase โ…ข Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN NCT07390123Phase 39 sites๐Ÿ“ Huangshan City๐Ÿ“ Wuhu๐Ÿ“ Beijing Haisco Pharmaceutical Group Co., Ltd. ยท Tests: HSK39297, Placebo Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. NCT06858319Phase 326 sites๐Ÿ“ Denver๐Ÿ“ Orlando๐Ÿ“ Iowa City Novartis Pharmaceuticals ยท Tests: zigakibart Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy NCT07074951NA2 sites๐Ÿ“ Saint Petersburg๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Immunosuppressive treatment, Tonsillectomy A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy NCT06676007n/a1 site๐Ÿ“ Chengdu Sichuan Provincial People's Hospital ยท Tests: Gd-IgA1 test Atacicept in Multiple Glomerular Diseases NCT06983028Phase 21 site๐Ÿ“ Brisbane Vera Therapeutics, Inc. ยท Tests: Atacicept Study of Ravulizumab in Pediatric Participants With Primary IgAN NCT07024563Phase 315 sites๐Ÿ“ Palo Alto๐Ÿ“ Aurora๐Ÿ“ Beijing Alexion Pharmaceuticals, Inc. ยท Tests: Ravulizumab National Registry of Rare Kidney Diseases NCT06065852n/a1 site๐Ÿ“ Bristol UK Kidney Association A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy NCT06963827Phase 3181 sites๐Ÿ“ Birmingham๐Ÿ“ Montgomery๐Ÿ“ Surprise Takeda ยท Tests: Mezagitamab, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy